Search Results
Search for other papers by Mohamed Asrih in
Google Scholar
PubMed
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
, insulin resistance, hypertension, and dyslipidemia, suggesting that NAFLD might be considered as the liver manifestation of the metabolic syndrome ( Marchesini et al . 2001 , Adams et al . 2005 ). The metabolic syndrome is a leading cause of mortality
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Susan Kralisch in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Anke Tönjes in
Google Scholar
PubMed
Search for other papers by Kerstin Krause in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Judit Richter in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Ulrike Lossner in
Google Scholar
PubMed
Search for other papers by Peter Kovacs in
Google Scholar
PubMed
Search for other papers by Thomas Ebert in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Matthias Blüher in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Michael Stumvoll in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Mathias Fasshauer in
Google Scholar
PubMed
and independently correlated with facets of the metabolic syndrome including obesity, insulin resistance, hypertension, and dyslipidemia in nondiabetic subjects. In agreement with this notion, circulating FGF21 is increased in T2DM compared with
Search for other papers by Jerzy Bełtowski in
Google Scholar
PubMed
Search for other papers by Grażyna Wójcicka in
Google Scholar
PubMed
Department of Pathophysiology, Department of Microbiology and Molecular Genetics, Department of Biochemistry and Biotechnology, Medical University, ul. Jaczewskiego 8, 20-090 Lublin, Poland
Search for other papers by Hieronim Jakubowski in
Google Scholar
PubMed
amount of adipose tissue and (acquired) resistance to anorectic effect of this hormone ( Considine et al . 1996 ). Obesity and the accompanying metabolic syndrome are the major risk factors of atherosclerosis but the underlying mechanisms are
Academy of Scientific and Innovative Research, CSIR-CDRI, Lucknow, India
Search for other papers by Sujith Rajan in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-IHBT, Palampur, India
Search for other papers by Ganesh Panzade in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-CDRI, Lucknow, India
Search for other papers by Ankita Srivastava in
Google Scholar
PubMed
Search for other papers by Kripa Shankar in
Google Scholar
PubMed
Search for other papers by Rajesh Pandey in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-CDRI, Lucknow, India
Search for other papers by Durgesh Kumar in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-CDRI, Lucknow, India
Search for other papers by Sanchita Gupta in
Google Scholar
PubMed
Search for other papers by Abhishek Gupta in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-CDRI, Lucknow, India
Search for other papers by Salil Varshney in
Google Scholar
PubMed
Search for other papers by Muheeb Beg in
Google Scholar
PubMed
Search for other papers by Raj Kumar Mishra in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-IHBT, Palampur, India
Search for other papers by Ravi Shankar in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-CDRI, Lucknow, India
Search for other papers by Anil Gaikwad in
Google Scholar
PubMed
at https://doi.org/10.1530/JOE-17-0387 . Discussion In this study, we have demonstrated that miR-876-3p regulates glucose homeostasis and its dysregulation leads to obesity-associated metabolic syndrome. Since no study specific to
Search for other papers by Isabel Huang-Doran in
Google Scholar
PubMed
Search for other papers by Alison Sleigh in
Google Scholar
PubMed
Search for other papers by Justin J Rochford in
Google Scholar
PubMed
Search for other papers by Stephen O'Rahilly in
Google Scholar
PubMed
Search for other papers by David B Savage in
Google Scholar
PubMed
direction with the loss of facial and upper limb fat preceding variable trunk fat loss. In our experience, people with this form of lipodystrophy only become insulin resistant and manifest other features of the metabolic syndrome when upper body fat loss
Search for other papers by Jinyu Ma in
Google Scholar
PubMed
Search for other papers by Yuejun Wang in
Google Scholar
PubMed
Search for other papers by Jie Ding in
Google Scholar
PubMed
Search for other papers by Shouping Zhang in
Google Scholar
PubMed
Search for other papers by Yinuo Yang in
Google Scholar
PubMed
Nantong Key Laboratory of Translational Medicine in Cardiothoracic Diseases, Institute of Translational Medicine in Cardiothoracic Diseases, Affiliated Hospital of Nantong University, Nantong, China
Search for other papers by Cheng Sun in
Google Scholar
PubMed
obesity at the early stages of the disease ( Ezenwaka et al. 2014 , Heianza et al. 2015 ). Abdominal obesity is an important cause of metabolic syndromes and impairs glucose tolerance ( Hossain et al. 2007 ). Therefore, slow or prevent body weight
Search for other papers by Gabriel Forn-Cuní in
Google Scholar
PubMed
Search for other papers by Monica Varela in
Google Scholar
PubMed
Search for other papers by Conrado M Fernández-Rodríguez in
Google Scholar
PubMed
Search for other papers by Antonio Figueras in
Google Scholar
PubMed
Search for other papers by Beatriz Novoa in
Google Scholar
PubMed
diseases are part of a condition termed metabolic syndrome. The hepatic component of metabolic syndrome is non-alcoholic fatty liver disease (NAFLD). This term comprises a wide range of progressive liver injuries including bland steatosis, variable degrees
Search for other papers by J Hoppmann in
Google Scholar
PubMed
Search for other papers by N Perwitz in
Google Scholar
PubMed
Search for other papers by B Meier in
Google Scholar
PubMed
Search for other papers by M Fasshauer in
Google Scholar
PubMed
Search for other papers by D Hadaschik in
Google Scholar
PubMed
Search for other papers by H Lehnert in
Google Scholar
PubMed
Search for other papers by J Klein in
Google Scholar
PubMed
metabolic syndrome ( Hotamisligil et al . 1993 , 1995 ). The crosstalk between adipocytes and macrophages which infiltrate adipose tissue in obesity is considered to be crucial for the development of the pro-inflammatory state ( Bluher 2008 ). To date, the
Search for other papers by Thomas Nicholson in
Google Scholar
PubMed
Search for other papers by Chris Church in
Google Scholar
PubMed
Search for other papers by Kostas Tsintzas in
Google Scholar
PubMed
Search for other papers by Robert Jones in
Google Scholar
PubMed
Search for other papers by Leigh Breen in
Google Scholar
PubMed
Search for other papers by Edward T Davis in
Google Scholar
PubMed
Search for other papers by David J Baker in
Google Scholar
PubMed
Search for other papers by Simon W Jones in
Google Scholar
PubMed
reported that the prevalence of metabolic syndrome is higher in females than in males ( Beigh & Jain 2012 ), with central adiposity being a greater risk factor for metabolic diseases in females ( Li et al. 2006 , Holliday et al. 2011 ). Contrary to
Search for other papers by Hanna E Auvinen in
Google Scholar
PubMed
Search for other papers by Johannes A Romijn in
Google Scholar
PubMed
Search for other papers by Nienke R Biermasz in
Google Scholar
PubMed
Search for other papers by Hanno Pijl in
Google Scholar
PubMed
Department of Endocrinology and Metabolic Diseases, TNO-Metabolic Health Research, Leiden University Medical Center, Room C5-R61, Albinusdreef 2, PO Box 9600, 2300 RC Leiden, The Netherlands
Search for other papers by Louis M Havekes in
Google Scholar
PubMed
Search for other papers by Johannes W A Smit in
Google Scholar
PubMed
Search for other papers by Patrick C N Rensen in
Google Scholar
PubMed
Search for other papers by Alberto M Pereira in
Google Scholar
PubMed
adaptations enabling the host to adequately coping with the stressor (fight or flight). Increased activity of the HPA axis has been linked to the development of the metabolic syndrome (MetS; Pasquali et al . 2006 ). The metabolic effects of GC are directed